The research collaboration between EraCal Therapeutics and Nestlé Health Science aims to identify novel nutraceuticals relevant to controlling food intake. The joint program combines Nestle's unique nutraceutical resources with EraCal's differentiated drug discovery platform. These synergies aim to provide a new paradigm for first-line nutraceuticals for people suffering from metabolic diseases.